Natera Inc. (NASDAQ:NTRA) on Wednesday revealed initial translational research results from the international randomized Phase 3 PALLAS study. Data were presented at the San Antonio Breast Cancer Symposium (SABCS). These first data, generated from a U.S. biomarker cohort of 420…
Uncategorized
Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) stock is higher on Thursday, after the company shared preliminary results from its exploratory Phase 2 trial of setmelanotide in patients with Prader-Willi syndrome (PWS). PWS is a rare genetic disorder characterized by muscle weakness and…
PayPal Holdings Inc (NASDAQ:PYPL) shares are trading higher on Thursday, bouncing back from earlier losses after BofA Securities cut its rating from Buy to Neutral and lowered its price target to $68 from $93. PayPal Holdings stock is showing downward…
The National Medical Products Administration (NMPA) in China has approved Sanofi SA’s (NASDAQ:SNY) two medicines for rare hematologic diseases: Qfitlia (fitusiran) for hemophilia and Cablivi (caplacizumab) for acquired thrombotic thrombocytopenic purpura. • Sanofi stock is showing upward movement. Why is…
XOMA Royalty Corporation (NASDAQ:XOMA) stock plunged on Thursday after its partner Rezolute Inc. (NASDAQ:RZLT) reported disappointing trial results for its partnered product, Ersodetug (RZ358). The company on Thursday released topline results from its Phase 3 sunRIZE study evaluating ersodetug in…
Wall Street analysts rerated Synopsys, Inc (NASDAQ:SNPS) after it reported its quarterly results on Wednesday. • Synopsys stock is trading in a tight range. What should traders watch with SNPS? Synopsys reported stronger-than-expected fourth-quarter results, posting adjusted earnings of $2.90…
Visa Inc. (NASDAQ:V) stock is on the rise Thursday after Bank of America Securities upgraded its rating on the stock. Visa stock is among today’s top performers. What’s driving V stock higher? What To Know: Analyst Mihir Bhatia upgraded Visa from…
GE Vernova’s (NYSE:GEV) latest Investor Day refreshed expectations with sharper financial targets and a more defined strategic roadmap, prompting analysts to reassess the company’s long-term trajectory. Seaport Global analyst Tom Curran now considers GEV fairly valued following the December 9…
When it comes to judging the health of the stock market and new all-time records being set, most investors track the Dow Jones Industrial Average, S&P 500 and Nasdaq 100. President Donald Trump showed which of these metrics he prefers…
Planet Labs PBC (NYSE:PL) stock climbed on Thursday as investors cheered the strengthening demand for its satellite imagery and data platform. Planet Labs stock is at critical resistance. What’s driving PL to record levels? The move reflects growing confidence in the…






